Chemesis International Corp.

Chemesis operates in the most important and most profitable sectors of the cannabis industry. By providing sound knowledge, structure and confident leadership, Chemesis will grow new markets and revenues within Cultivation, Manufacturing, Distribution and Retail Sales.

With current operations underway in Puerto Rico with Natural Ventures, Colombia with La Finca, and California with California Sap and Desert Zen. Chemesis is positioned for rapid growth in the emerging fully-licensed and fully-compliant cannabis industry.

Starting with their state of the art grow facility in Puerto Rico, which showcases a 2000+ grow light capacity and a 30,000+ lb overall grow capacity, Chemesis has multiple expansion opportunities currently under review in both Puerto Rico and California. La Finca brings over 1,000 acres of land for cultivation in Colombia. Chemesis has over 2,000 relationships with farming families that comprise its land package.

Chemesis is able to offer its clients all types of extractions, formulations & products, specializing in BHO Extraction, Alcohol Extraction, and CO2 Extraction and currently has the capacity to process over 2,000 lbs of raw material per day.

With new regulations impacting the California market, Desert Zen has emerged as a fully compliant first mover.

Desert Zen currently has a significant footprint in Southern California, and the company has a fleet of fully compliant vehicles that are servicing the state.

Chemesis is currently retailing exclusive products in Puerto Rico and actively engaging retail storefronts in the California market. In addition, Chemesis is working to open exclusively branded shops in multiple marketplaces. Chemesis distributes and transports California Sap, Jay and Silent Bob’s Private Stash, as well as third party brands to over 600 dispensaries in California and Puerto Rico.

The Big Book Of Pot Investments


THIS REPORT/ADVERTORIAL (“ADVERTORIAL”) IS A PAID COMMERCIAL ADVERTISEMENT AND IS FOR GENERAL INFORMATION PURPOSES ONLY. Neither The Trading Letter nor Daryl Thompson (“Endorser) is making a recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by readers that learn of the profiled companies through this website. This Advertorial was paid for by a non-issuer third party in an effort to enhance public awareness of Chemesis International Inc. and its securities. has or will receive $30,000 in cash in connection with this effort. Endorser has or will receive compensation in the form of leads valued at approximately $1,000 that are expected to result in additional subscription revenue in connection with this effort. Neither nor Endorser currently holds the securities of Chemesis International Inc. and do not currently intend to purchase such securities. Endorser is solely responsible for and has ultimate authority over the Advertorial and contents of the statements contained in this Advertorial. This Advertorial is based exclusively on information generally available to the public and does not contain any material, non-public information. Neither nor Endorser warrants the accuracy of such information. Certain statements contained in this Advertorial may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as "believes," "anticipates," "estimates," “expects," "projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Neither nor Endorser undertakes an obligation to update forward-looking statements in light of new information or future events. Readers can review all public SEC filings made by the featured company at

Neither nor Endorser are licensed in the securities industry in any manner. Please review all investment decisions with a licensed investment advisor.